RLAY vs MSFT: Which Stock is Better?
Side-by-side comparison of Relay Therapeutics Inc and Microsoft Corporation in 2026
RLAY
Relay Therapeutics Inc
$18.50
MSFT
Microsoft Corporation
$499.32
Key Metrics Comparison
| Metric | RLAY | MSFT | Winner |
|---|---|---|---|
| Market Cap | $3.39B | $3.71T | MSFT |
| P/E Ratio | N/A | 33.89 | RLAY |
| EPS (TTM) | $N/A | $14.08 | MSFT |
| Revenue Growth | -23.3% | 18.4% | MSFT |
| Gross Margin | 0.0% | 67.9% | MSFT |
Analyze RLAY
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is RLAY or MSFT a better investment?
Comparing RLAY and MSFT: Relay Therapeutics Inc has a market cap of $3.39B while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between RLAY and MSFT?
RLAY (Relay Therapeutics Inc) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: RLAY or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: RLAY or MSFT?
MSFT has higher revenue growth at 18.4% vs -23.3% for RLAY.
Which company is more profitable: RLAY or MSFT?
Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for RLAY.
Which is the larger company: RLAY or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $3.39B for RLAY.
Should I buy RLAY or MSFT in 2026?
Both RLAY and MSFT have investment merit. RLAY trades at $18.50 while MSFT trades at $499.32. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between RLAY and MSFT stock?
Key differences: Market Cap ($3.39B vs $3.71T), P/E Ratio (N/A vs 33.9x), Revenue Growth (-23.3% vs 18.4%), Gross Margin (0.0% vs 67.9%).
Should I buy RLAY or MSFT in 2026?
The choice between RLAY and MSFT depends on your investment goals. MSFT shows higher revenue growth (18.4%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between RLAY and MSFT?
RLAY (Relay Therapeutics Inc) has a market cap of $3.39B, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.